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a b s t r a c t
Aim: Mitral stenosis (MS) is found to produce left ventricular (LV) dysfunction in some
studies. We sought to study the left ventricular function in patients with rheumatic MS
undergoing balloon mitral valvotomy (BMV). Ours is the ﬁrst study to analyze effect of BMV
on mitral annular plane systolic excursion (MAPSE), and to quantify prevalence of longitu-
dinal left ventricular dysfunction in rheumatic MS.
Methods: In this prospective cohort study, we included 43 patients with severe rheumatic
mitral stenosis undergoing BMV. They were compared to twenty controls whose distribution
of age and gender were similar to that of patients. The parameters compared were LV
ejection fraction (EF) by modiﬁed Simpson's method, mitral annular systolic velocity
(MASV), MAPSE, mitral annular early diastolic velocity (E0), and myocardial performance
index (MPI). These parameters were reassessed immediately following BMV and after
3 months of procedure.
Results: MASV, MAPSE, E0, and EF were signiﬁcantly lower and MPI was higher in mitral
stenosis group compared to controls. Impaired longitudinal LV function was present in 77%
of study group. MAPSE and EF did not show signiﬁcant change after BMV while MPI, MASV,
and E0 improved signiﬁcantly. MASV and E0 showed improvement immediately after BMV,
while MPI decreased only at 3 months follow-up.
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E-mail address: drrajeshgnair@gmail.com (G.N. Rajesh).
Abbreviations: MS, mitral stenosis; BMV, balloon mitral valvotomy; LV, left ventricle; EF, ejection fraction; MAPSE, mitral annular plane
systolic excursion; MASV, mitral annular systolic velocity; E0, early diastolic mitral annular velocity; MPI, myocardial performance index;
TDE, tissue Doppler echocardiography; RHD, rheumatic heart disease; AF, atrial ﬁbrillation; ROC, receiver–operating characteristics; IVCT,
isovolumic contraction time; IVRT, isovolumic relaxation time.
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Conclusions: There were signiﬁcantly lower mitral annular motion parameters including
MAPSE in patients with rheumatic mitral stenosis. Those with atrial ﬁbrillation had higher
MPI. Immediately after BMV, there was improvement in LV long axis function with a gradual
improvement in global LV function. There was no signiﬁcant change of MAPSE after BMV.
# 2015 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Left ventricular (LV) dysfunction has been described in mitral
stenosis (MS),1–4 which may be a due to change in interaction
between right and left ventricles, myocardial ﬁbrosis or a
chronic decrease in preload.5 Even with normal ejection
fraction (EF) (indicating preserved global left ventricular
function), there can be impairment in long-axis function
(measured by tissue Doppler echocardiography).6,7 Altered LV
long-axis movement has been shown to be a sensitive
indicator of early myocardial dysfunction. Atrial ﬁbrillation
has shown to cause impairment of LV function. Pulsed-wave
Doppler tissue velocities have been proven to be a good tool for
assessment of long-axis ventricular shortening and lengthen-
ing. There are no previous studies on mitral annular plane
systolic excursion (MAPSE) in mitral stenosis and the effect of
balloon mitral valvotomy (BMV) on it. The previous studies61 patients undergoing BMV screened
Excluded 43 patients included
12 –concomittant significa nt other valvular involvement 2 patients lost follow up
2-Hypertension                                                                     41 patients completed follow up
3-Diabetes mellitus
1-Significant coronary stenosishave utilized myocardial performance index (MPI), mitral
annular systolic velocity (MASV), and early mitral annular
diastolic velocity (E0). Previous studies have not quantiﬁed the
prevalence of longitudinal LV dysfunction in rheumatic MS.
We sought to study the various echo parameters of LV function
in rheumatic mitral stenosis and effect of BMV on these indices.
2. Methods
2.1. Study population
In a prospective cohort study conducted at a tertiary care
hospital in Kerala, the southernmost state of India, patients ofsevere MS undergoing BMV from August 2013 to March 2014
were screened. Patients with more than mild stenosis or
regurgitation of other valves, evidence of coronary artery
disease (symptomatic, electrocardiographic or angiographic),
hypertension and diabetes mellitus were excluded. Of a total
of 61 patients screened, 2 had hypertension, 3 had diabetes
mellitus, 1 had signiﬁcant coronary artery disease (underwent
PTCA to LAD), and 12 patients were excluded due to more than
mild concomitant valve involvement. 20 controls, whose
distribution of age and gender was similar to that of
patients, were chosen from healthy controls with no cardiac
symptoms, good effort tolerance, normal ECG and no
structural heart disease undergoing echocardiography. Data
were collected after getting informed consent from the
patients and institutional ethics committee approval. Study
conforms to widely accepted ethical principles guiding human
research.2.2. Echocardiography
Echocardiography was done by Philips HD11 XE system, using
probe frequency range of 2–4 MHz. A single investigator did all
the echocardiographic evaluation (except for assessing inter-
observer variability, where 2 investigators were involved). All
echocardiographic measurements were taken as mean of 3
consecutive cycles in those in sinus rhythm and 5 consecutive
cycles in AF. Modiﬁed Simpson's method was used to assess
ejection fraction (after measuring end diastolic and end
systolic volumes). Mitral valve area was calculated by
planimetry (measurement obtained by direct tracing of the
mitral oriﬁce at the leaﬂet tip, on a parasternal short-axis
Fig. 1 – (A) Measurement of mitral annular plane systolic excursion: The systolic excursion of mitral annulus was measured
from the lowest point at end-diastole to aortic valve closure (end of the T-wave on the electrocardiogram). (B) Measurement of
myocardial performance index: in the apical 4-chamber view, TDE cursor was placed at the septal and lateral side of the
mitral annulus. In the apical 2-chamber view, the TDE cursor was placed at the anterior and inferior sides of the mitral
annulus in the same manner. Myocardial performance index was calculated by dividing the sum of IVCT and IVRT by
ejection time. (C) ROC curve.
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mitral pressure gradients were obtained by continuous wave
Doppler. The systolic pulmonary artery pressure was derived
from the tricuspid regurgitant jet velocity by means of the
modiﬁed Bernoulli equation. MAPSE was measured by M-
mode images obtained at the LV septal, lateral, anterior, and
posterior borders of the mitral ring in the apical 2-chamber and
4-chamber views, and an average MAPSE value was calculat-
ed8 (Fig. 1A). In the apical four-chamber view, the tricuspid
annular plane systolic excursion was measured by the level of
systolic excursion of the lateral tricuspid valve annulus
towards the apex.9
Sweep speed of 100 mm/s was used to assess pulsed wave
tissue Doppler tracings. In the apical 4-chamber view, TDE
cursor was placed at the septal and lateral sides of the mitral
annulus. In the apical 2-chamber view, the TDE cursor was
placed at the anterior and inferior sides of the mitral annulus.
Myocardial performance index was calculated by dividing the
sum of IVCT and IVRT by ejection time. Peak velocities during
systole (S0) and early diastole (E') were measured. Average
value from four sites was obtained (Fig. 1B).
An experienced team performed BMV monitoring of
conventional hemodynamic parameters. Balloon size was
chosen according to height.10 Percutaneous BMV was regarded
as successful if the mitral valve area post-percutaneous BMV
was >1.5 cm2 or the gain was >50% of baseline with no
signiﬁcant mitral regurgitation.11
2.3. Follow-up
Follow-up was done within 24 h after BMV, and 3 months after
discharge. Though most of the previous studies have follow-
up analysis at 48–72 h post BMV, we chose to do it within 24 h
as it was an institution policy to discharge uncomplicated
successful BMV patients after 24 h. As parameters were
assessed within 24 h, we did not analyze MVA by pressurehalftime, as it may be inaccurate during this period. Patients
were evaluated with echocardiogram and various indices of LV
function were reassessed.
2.4. Statistical analysis
Statistical analysis was performed with SPSS software version
18 (SPSS Inc., Chicago, IL). Qualitative variables, expressed as
numbers and percentages were compared by the Chi-square
test. Quantitative variables among study group and control
group were compared by Mann–Whitney U test and those at
three different time intervals were done with repeated
measure ANOVA. Receiver operating characteristics curve
was plotted to get the best cut off predictor for deﬁning
longitudinal LV dysfunction (Fig. 1C). Multivariate analysis was
done to identify the various factors affecting left ventricular
function. P value less than 0.05 was considered signiﬁcant.
3. Results
3.1. Baseline
There were 43 patients (25 in sinus rhythm) in the study group
and 20 subjects in control group. Majority were females with
no signiﬁcant gender difference in either group (79.1% vs. 75%,
p = 0.718). Heart rates were also similar (p = 0.084). The baseline
characteristics of the study and control population are
depicted in Table 1. Intra-class coefﬁcient was analyzed for
assessing inter and intra-observer variabilities. For intra-
observer variability, intra-class coefﬁcients were MASV – 0.95,
MPI – 0.86, E0 – 0.91, and MAPSE – 0.97. For inter-observer
variability, intra-class coefﬁcients were MASV – 0.92, MPI –
0.84, E0 – 0.89, and MAPSE – 0.96. All the parameters had intra-
class coefﬁcient more than 0.7 (acceptable range 0.7–1).
Maximum intra and inter-observer variabilities were for MPI.
Table 1 – Baseline characteristics.
Parameter Mitral stenosis Controls p value
Age (years) 40.05 (12.59) 43.30 (8.23) 0.174
Duration (years) 6.16 (0.456) NA –
Heart rate (bpm) 82.60 (17.18) 76.00 (8.89) 0.084
2D MVA (cm2) 0.85 (0.10) NA –
Mean MVG (mm Hg) 14.31 (5.97) NA –
TAPSE (mm) 18.67 (1.50) 18.82 (1.40) 0.778
EF (%) 58.38 (4.70) 63.18 (3.85) <0.001
EDVI (ml/m2) 58.41 (17.95) 52.20 (8.79) 0.149
MAPSE (mm) 11.35 (4.72) 13.07 (1.44) <0.001
MASV (cm/s) 7.28 (1.26) 8.57 (0.67) <0.001
E0 (cm/s) 7.68 (1.46) 8.55 (1.54) 0.033
MPI 0.59 (0.12) 0.46 (0.06) <0.001
All values are given as mean (SD).
MVA, mitral valve area; MVG, mitral valve gradient; TAPSE,
tricuspid annular plane systolic excursion; EF–ejection fraction,
EDVI, end diastolic volume index; MAPSE, mitral annular plane
systolic excursion; E0, early mitral annular diastolic velocity; MPI,
myocardial performance index.
Table 3 – Comparison of pre BMV and post BMV
parameters.
Parameter Pre BMV
(group 1)
Post BMV
(group 2)
3-month
follow-up
(group 3)
Mean SD Mean SD Mean SD
MPI 0.587 0.020 0.582 0.028 0.488 0.012
MASV (cm/s) 7.274 0.201 7.951 0.195 8.015 0.187
E0 (cm/s) 7.677 0.234 8.015 0.226 8.331 0.229
p values-MASV, E0-group 2 to group 1 = <0.001, 0.04, respectively.
MPI, E0 group 3 to group 2 = 0.002, <0.001, respectively.
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 6 1 2 – 6 1 7 6153.1.1. Comparison of LV Function in sinus rhythm vs. AF
There were 25 patients in sinus rhythm, while 18 had AF.
They were comparable with respect to age, gender, and
duration of symptoms. Ejection fraction was not signiﬁcantly
different between two groups. Of the other baseline LV
parameters, only MPI (p = 0.04) was signiﬁcantly higher in the
AF group. The various parameters are compared in Table 2.
Patients with atrial ﬁbrillation were noted to have better
improvement in MPI at 3 months follow-up post BMV as
compared to those in sinus rhythm (p = 0.006). All other
parameters of LV function including MPI immediate post
BMV were not signiﬁcantly different in atrial ﬁbrillation and
sinus rhythm group.Table 2 – Comparison of characteristics of patients with
sinus rhythm vs. atrial fibrillation at baseline.
Parameter Sinus rhythm AF p value
Age (years) 37.56 (12.01) 43.50 (12.89) 0.146
Duration (years) 6.64 (4.54) 5.50 (4.64) 0.12
Heart rate (bpm) 79.40 (14.09) 87.06 (20.33) 0.112
2D MVA (cm2) 0.85 (0.11) 0.84 (0.09) 0.76
Mean MVG (mm Hg) 15.85 (6.89) 12.17 (3.59) 0.156
TAPSE (mm) 18.92 (1.47) 18.31 (1.51) 0.401
EF (%) 59.06 (5.47) 57.43 (3.27) 0.506
EDVI (ml/m2) 60.89 (19.94) 55.24 (14.99) 0.323
MAPSE (mm) 11.62 (6.07) 10.98 (1.67) 0.247
MASV (cm/s) 7.66 (0.77) 6.75 (1.59) 0.09
E0 (cm/s) 7.75 (1.32) 7.57 (1.68) 0.931
MPI 0.55 (0.11) 0.64 (0.12) 0.04
All values are given as mean (standard deviation).
MVA, mitral valve area; MVG, mitral valve gradient; TAPSE,
tricuspid annular plane systolic excursion; EDVI, end diastolic
volume index; MAPSE, mitral annular plane systolic excursion;
MASV, mitral annular systolic velocity; E0, early mitral annular
diastolic velocity; MPI, myocardial performance index; AF, atrial
ﬁbrillation.3.2. Follow-up
Mean post-BMV 2D MVA was 1.47 cm2 (SD 0.11) and average
mitral valve mean gradient was 3.97 mm Hg (SD 1.12). EF and
MAPSE did not show signiﬁcant change immediate post BMV
or at 3-month follow-up ( p value = 0.524, 0.830, respectively).
MASV showed immediate increase after BMV, but did
not show further improvement at 3-month follow-up. E0
improvement was seen immediately after BMV, and
further signiﬁcant improvement was noted at 3-month
follow-up. MPI failed to show any change immediate post
BMV but decreased signiﬁcantly at 3-month follow-up
(Table 3).
There was no signiﬁcant difference in left ventricular
systolic and diastolic volumes either immediately or 3 months
after BMV.
Receiver–operating characteristic (ROC) curve (Fig. 1C)
was plotted with the 3 parameters of longitudinal LV
function-MASV, MAPSE, and E0. Based on that, MASV with
a cut of value of 8.1 cm/s was selected as the best parameter
to classify the study group into those with normal LV
longitudinal function and with reduced LV longitudinal axis
function (MASV < 8.1 cm/s). 77% of those in study group
had LV longitudinal dysfunction, which decreased to 27% at
3-month follow-up. Thus BMV improved LV long axis
function (p < 0.01).
3.2.1. Predictors of improvement in LV function
Magnitude of improvement in left ventricular longitudinal
function was correlated with age, duration of symptoms and
degree of baseline dysfunction. Only those indices that
showed a signiﬁcant change after BMV were taken for this
analysis. On multivariate analysis, improvement in LV
function indices did not show any correlation to age, duration
of symptoms, or to baseline TAPSE. Magnitude of change in
MPI post-BMV showed inverse correlation to baseline MPI.
Findings are summarized in Table 4. Patients with atrial
ﬁbrillation were noted to have better improvement in MPI at 3
months follow-up post BMV as compared to those in sinus
rhythm (p = 0.006).
The improvement in various parameters of LV function was
independent of change in LV volumes. There was no
correlation between NYHA functional class and longitudinal
LV function both before and after BMV (p = 0.372, 0.642,
respectively). There was no statistical correlation between
longitudinal LV function and Wilkins echo score (p = 0.21).
Table 4 – Change in LV function parameters correlated to age, gender, duration of symptoms, improvement in mitral valve
area and baseline parameter value.
Variable MASV E0 MPI
b p value b p value b p value
Age 0.057 0.76 0.36 0.03 0.02 0.8
Gender 0.056 0.75 0.16 0.27 0.04 0.6
Duration of symptoms 0.125 0.47 0.027 0.86 0.05 0.63
Baseline same parameter value 0.38 0.035 0.39 0.02 0.7 0.001
MASV, mitral annular systolic velocity; E0, early mitral annular diastolic velocity; MPI, myocardial performance index; MVA, 2D mitral valve
area; r, coefﬁcient of correlation; b, beta coefﬁcient.
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4.1. Left ventricular dysfunction in rheumatic mitral
stenosis
In patients with MS, varying degrees of deterioration in LV
function has been reported. The data on the prevalence of
longitudinal left ventricular dysfunction in rheumatic mitral
stenosis are not enough. Our study showed lower MAPSE,
MASV, and E0, with higher MPI in mitral stenosis patients
compared to controls. In our study, 77% of study group had
evidence of LV longitudinal dysfunction. The higher preva-
lence of longitudinal LV dysfunction in our group may be due
to the fact that we have taken only patients with severe MS.
Other factors that may have contributed to this are the delay to
medical care from onset of symptoms, as well as earlier onset
of valvular disease in Indian population. The study by Ozdemir
et al.6 showed that MS affects long axis left-ventricular
performance. The myocardial velocities of the left ventricle
indicating left-ventricular function were found to be signiﬁ-
cantly lower in patients with pure MS. Ozer et al.7 examined
left ventricular long-axis function of patients with pure MS.
There was no signiﬁcant difference in global systolic function,
but tissue Doppler systolic velocities were signiﬁcantly lower
in patients with mitral stenosis than in controls. Our study
showed lower indices of LV function (MPI) in AF subset, though
EF difference was non-signiﬁcant between the groups. In
patients with MS and AF, the causative mechanisms of LV
dysfunction are not well known.
4.2. Improvement of longitudinal function after BMV
In our study, EF and MAPSE did not show signiﬁcant change
with BMV. Mitral annular systolic velocity and E0 showed
improvement immediate post-BMV, while MPI showed a
decrease only at 3-month follow-up. The immediate improve-
ment of LV long axis parameters may be due to mechanical
effect of BMV, while improvement of MPI (indicating global LV
function) took longer time. Another possible explanation for
lack of MPI change immediate post BMV could be due to the
fact that MPI, though averaged for 5 cycles in AF patients, could
produce signiﬁcant intra observer variability. In a study by Lee
and colleagues,12 most patients with impaired LV ejection
fraction showed improvement after mitral valvuloplasty.
Study by Sengupta et al.13 showed that after BMV, MASV
and E0 showed signiﬁcant improvement, which is similar to
our outcome. A study by Nurcan et al.14 which included 76consecutive patients, who underwent BMV for isolated
rheumatic mitral stenosis, showed improvement in MASV
and E0 post-BMV. Left ventricular global function by MPI did not
improve signiﬁcantly 48 h and three months after BMV. This is
in contrast to results of our study, which showed a decrease in
MPI at 3 months following BMV. Thus serial evaluation of
changes in mitral annular velocities by Doppler tissue imaging
aids clinical assessment of immediate improvement in left
ventricular function after BMV.
4.3. Predictors of improvement of LV longitudinal function
Our study showed that magnitude of change in MPI post-BMV
had inverse correlation to baseline MPI. The improvement of
global LV function after BMV is thus inversely correlated to
baseline global LV function. Hence, it may be assumed that
performance of early BMV, before signiﬁcant worsening of
global LV function may yield better long-term outcomes, and
needs to be assessed by future studies with larger sample size.
5. Conclusions
There was a signiﬁcant reduction in left ventricular function
parameters in severe rheumatic mitral stenosis. Impaired LV
long axis function was present in 77% of study group. Those
with atrial ﬁbrillation had higher MPI compared to those in
sinus rhythm (indicating a worse global LV function).
Immediately after BMV, there was an improvement in LV
long axis function. There was a gradual improvement in global
left ventricular function post-BMV.
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